These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37712527)

  • 1. Point prevalence probing of antimicrobial prescription patterns from a developing country.
    Khursheed N; Ahsan Q; Rattani S; Fatima M; Raza A; Tariq S; Mustafa T; Ahmed K; Iqbal S; Zulfiqar S; Ahmed SM; Fatima G; Akbar Khan S; Ullah F; Ahmed RA; Jamal S
    Expert Rev Anti Infect Ther; 2023 Sep; ():1-8. PubMed ID: 37712527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of antimicrobial stewardship programmes and antibiotic use among children admitted to two hospitals in Sierra Leone: a cross-sectional study.
    Kamara IF; Fofanah BD; Nuwagira I; Kamara KN; Tengbe SM; Abiri O; Kamara RZ; Lakoh S; Farma L; Kamara AK; Hailu B; Dove D; Squire JS; D'Almeida SA; Sheriff B; Mustapha A; Bawa N; Lagesse H; Koroma AT; Kanu JS
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):80. PubMed ID: 39039593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey.
    Abubakar U
    BMC Infect Dis; 2020 Jan; 20(1):86. PubMed ID: 32000722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey.
    Palaiopanos K; Krystallaki D; Mellou K; Kotoulas P; Kavakioti CA; Vorre S; Vertsioti G; Gkova M; Maragkos A; Tryfinopoulou K; Paraskevis D; Tsiodras S; Zaoutis T
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):11. PubMed ID: 38273402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey.
    Labi AK; Obeng-Nkrumah N; Nartey ET; Bjerrum S; Adu-Aryee NA; Ofori-Adjei YA; Yawson AE; Newman MJ
    Antimicrob Resist Infect Control; 2018; 7():15. PubMed ID: 29423190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
    Gharbi M; Doerholt K; Vergnano S; Bielicki JA; Paulus S; Menson E; Riordan A; Lyall H; Patel SV; Bernatoniene J; Versporten A; Heginbothom M; Goossens H; Sharland M;
    BMJ Open; 2016 Nov; 6(11):e012675. PubMed ID: 27810974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications.
    Saleem Z; Haseeb A; Godman B; Batool N; Altaf U; Ahsan U; Khan FU; Mustafa ZU; Nadeem MU; Farrukh MJ; Mugheera M; Rehman IU; Khan AF; Saeed H; Hossain MA; Raafat M; Radwan RM; Iqbal MS
    Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey.
    Seni J; Mapunjo SG; Wittenauer R; Valimba R; Stergachis A; Werth BJ; Saitoti S; Mhadu NH; Lusaya E; Konduri N
    BMJ Open; 2020 Dec; 10(12):e042819. PubMed ID: 33323448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global point prevalence survey of antimicrobial consumption in Brazilian hospitals.
    Porto APM; Goossens H; Versporten A; Costa SF;
    J Hosp Infect; 2020 Feb; 104(2):165-171. PubMed ID: 31678430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ground level utility of Access, Watch, Reserve classification: Insights from a tertiary care center in North India.
    Negi G; Kb A; Panda PK
    World J Exp Med; 2023 Dec; 13(5):123-133. PubMed ID: 38173545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point Prevalence Surveys of Antimicrobial Prescribing in a Non-Acute Care Hospital in Saitama Prefecture, Japan.
    Ishibashi N; Pauwels I; Tomori Y; Gu Y; Yamaguchi T; Handa T; Yamaoka M; Ito D; Sakimoto T; Kimura T; Takizawa K; Sato R; Sakashita T; Ooyama A; Versporten A; Goossens H; Tarumoto N; Maesaki S; Tanahashi N
    Can J Infect Dis Med Microbiol; 2022; 2022():2497869. PubMed ID: 35368518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications.
    Saleem Z; Hassali MA; Versporten A; Godman B; Hashmi FK; Goossens H; Saleem F
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):285-293. PubMed ID: 30755077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point Prevalence Survey of Antimicrobial Use in Selected Tertiary Care Hospitals of Pakistan Using WHO Methodology: Results and Inferences.
    Ambreen S; Safdar N; Ikram A; Baig MZI; Farooq A; Amir A; Saeed A; Sabih F; Ahsan Q; Zafar A; Mahipala PG; Saleem Z; Salman M
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374306
    [No Abstract]   [Full Text] [Related]  

  • 14. A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals.
    Limato R; Nelwan EJ; Mudia M; de Brabander J; Guterres H; Enty E; Mauleti IY; Mayasari M; Firmansyah I; Hizrani M; Hamers RL
    JAC Antimicrob Resist; 2021 Jun; 3(2):dlab047. PubMed ID: 33937773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point Prevalence Survey of Antimicrobial Prescribing in a Nigerian Hospital: Findings and Implications on Antimicrobial Resistance.
    Fowotade A; Fasuyi T; Aigbovo O; Versporten A; Adekanmbi O; Akinyemi O; Goossens H; Kehinde A; Oduyebo O
    West Afr J Med; 2020; 37(3):216-220. PubMed ID: 32476113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point prevalence survey of antimicrobial use in three hospitals in North-Eastern Tanzania.
    Horumpende PG; Mshana SE; Mouw EF; Mmbaga BT; Chilongola JO; de Mast Q
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):149. PubMed ID: 32894182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO-Point Prevalence Survey of Antibiotic Use Among Inpatients at a Core National Antimicrobial Consumption Network Site in North India: Findings and Implications.
    Mittal N; Mittal R; Goel N; Parmar A; Bahl A; Kaur S; Gudibanda KR; Dudhraj V; Singh SK
    Microb Drug Resist; 2023 Jan; 29(1):1-9. PubMed ID: 36656989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Consumption and Deviation of Prescribed Daily Dose From the Defined Daily Dose in Critical Care Patients: A Point-Prevalence Study.
    Nunes PHC; Moreira JPL; Thompson AF; Machado TLDS; Cerbino-Neto J; Bozza FA
    Front Pharmacol; 2022; 13():913568. PubMed ID: 35784694
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic use among hospitalised patients in Sierra Leone: a national point prevalence survey using the WHO survey methodology.
    Kamara IF; Kanu J; Maruta A; Fofanah BD; Kamara KN; Sheriff B; Katawera V; D'Almeida SA; Musoke R; Nuwagira I; Lakoh S; Kamara RZ; Tengbe SM; Mansaray AR; Koroma Z; Thomas F; Abiri OT; Koroma AT; Russell JBW; Squire J; Vandi MA
    BMJ Open; 2023 Dec; 13(12):e078367. PubMed ID: 38159961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic use at a tertiary hospital in Tanzania: findings from a point prevalence survey.
    Katyali D; Kawau G; Blomberg B; Manyahi J
    Antimicrob Resist Infect Control; 2023 Oct; 12(1):112. PubMed ID: 37817204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.